| LUS | |||
---|---|---|---|---|
Positive | Negative | Total | ||
CXR | Positive | 21 | 0 | 21 |
Negative | 16 | 5 | 21 | |
Total | 37 | 5 | 42 | |
Index | Estimate | SE | Lower 95% CI | Upper 95% CI |
Cohen’s kappa (κ) | 0.238 | 0.097 | 0.048 | 0.428 |
Bias-adjusted kappa (BAK) | 0.109 | Â | Â | Â |
Prevalence and bias-adjusted kappa (PABAK) | 0.238 | Â | Â | Â |
 |  | CCT | ||
CXR | Â | Positive | Negative | Total |
Positive | 21 | 0 | 21 | |
Negative | 19 | 2 | 21 | |
Total | 40 | 2 | 42 | |
Index | Estimate | SE | Lower 95% CI | Upper 95% CI |
Cohen’s kappa (κ) | 0.095 | 0.065 |  − 0.033 | 0.223 |
Bias-adjusted kappa (BAK) |  − 0.138 |  |  |  |
Prevalence and bias-adjusted kappa (PABAK) | 0.095 | Â | Â | Â |
 | CCT | |||
Positive | Negative | Total | ||
LUS | Positive | 37 | 0 | 37 |
Negative | 3 | 2 | 5 | |
Total | 40 | 2 | 42 | |
Index | Estimate | SE | Lower 95% CI | Upper 95% CI |
Cohen’s kappa (κ) | 0.540 | 0.227 | 0.095 | 0.985 |
Bias adjusted kappa (BAK) | 0.532 | Â | Â | Â |
Prevalence and bias adjusted kappa (PABAK) | 0.857 | Â | Â | Â |